Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)
Increasing Shared Decision Making and Patient Participation in Lung Cancer Clinical Trials (Free to Breathe)
2 other identifiers
interventional
44
1 country
1
Brief Summary
This clinical trial studies how well the Decision Counseling Program works in increasing patient-physician shared decision making and participation in clinical trials for lung cancer patients. Decision aids help provide patients with information that may help them select a course of action related to their cancer care when more than one alternative is available. It also encourages shared decision making allowing patients and their providers to make health decisions together. Determining how patients make decisions about participating in a clinical trial may help doctors facilitate patient decision making and improve participation in lung cancer clinical trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Aug 2017
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 3, 2017
CompletedFirst Submitted
Initial submission to the registry
January 25, 2019
CompletedFirst Posted
Study publicly available on registry
January 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2020
CompletedApril 29, 2025
April 1, 2025
2.5 years
January 25, 2019
April 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Patient perception related to clinical trials participation, measured by follow up survey questions
Will compute descriptive statistics for all sections and determine the variables on which to compare patient responses at the two time points (baseline and endpoint) using paired t-tests.
Baseline to 30 days
Study Arms (1)
Decision Counseling
EXPERIMENTALPatients undergo participation in the DCP prior to an audio-recorded oncology appointment.
Interventions
Eligibility Criteria
You may qualify if:
- Patients diagnosed with lung cancer (Stages 0, 1, 2, 3, 4)
- Lung cancer patients for which there is an available interventional clinical trial open at Jefferson Kimmel Cancer Center
- Patients being treated by a lung medical oncologist on the Center City Campus of Thomas Jefferson University
- Able to provide informed consent
- English-speaking
You may not qualify if:
- Inability to communicate in English
- Unable to provide informed consent
- Not eligible for an open, actively accruing interventional trial at Jefferson
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Leader, DrPH
Sidney Kimmel Cancer Center at Thomas Jefferson University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2019
First Posted
January 29, 2019
Study Start
August 3, 2017
Primary Completion
February 1, 2020
Study Completion
March 28, 2020
Last Updated
April 29, 2025
Record last verified: 2025-04